ClinicalTrials.govpublic full text
Romosozumab Versus Denosumab in Glucocorticoid-induced Osteoporosis: an Extended Observation of a Randomized Controlled Trial at 48 Months
osteoporosis, glucocorticoids toxicity, glucocorticoids, fracture, romosozumab, denosoumab, outcome, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 995588
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.